- Home
- Your Messages
-
Smartest Doc
Daily Quiz CompetitionTest your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
New! PHYSICIAN REVIEW
Thousands of questions to assess your knowledge and aid exam prep!
- Physician Jobs (601)
- More
- Other Specialty
Rheumatology - Autoimmune/Heritable News & Articles
What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
- Our medical editors bring you the best key learnings published in the top peer-reviewed rheumatology medical journals. You'll find overviews here ranked and organized by topic on rheumatoid arthritis, joint and back pain, osteoarthritis, lupus and autoimmune diseases, osteoporosis and bone fractures. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
- MDLinx exclusive content includes monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, as well as clinical pearls from The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Hypovitaminosis D common in SLE -
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
Smartest Doc Challenge
MDLinx
Clinical Pearls for Rheumatologists -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest (2) Full Text Articles (22) Focus on Osteoporosis81 Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010) Rheumatology, April 25, 2013 Review Article
82 Relapsing Polychondritis Rheumatic Disease Clinics of North America, April 25, 2013 Review Article
83 Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases Immunologic Research, April 25, 2013 Clinical Article
84 Epilepsy Associated with Systemic Autoimmune Disorders Full Text Epilepsy Currents, April 25, 2013 Clinical Article
85 Localized Cutaneous Fibrosing Disorders Rheumatic Disease Clinics of North America, April 25, 2013 Review Article
86 Autoantibodies in Polymyositis and Dermatomyositis Current Rheumatology Reports, April 24, 2013 Review Article
87 Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature Immunologic Research, April 24, 2013 Review Article Clinical Article
88 Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials Journal of Autoimmunity , April 24, 2013 Clinical Article
89 B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases Journal of Autoimmunity , April 24, 2013 Clinical Article
90 Refractory pemphigus foliaceus and Behçets disease successfully treated with tocilizumab Immunologic Research, April 24, 2013
91 The prevalence of fibromyalgia in patients with Behcets disease and its relation with disease activity Rheumatology International, April 23, 2013 Clinical Article
92 Erdheim-Chester Disease Rheumatic Disease Clinics of North America, April 23, 2013 Review Article
93 Association of TNFSF4 polymorphisms with susceptibility to primary Sjogren`s syndrome and primary biliary cirrhosis in a Chinese Han population Clinical and Experimental Rheumatology Online, April 23, 2013 Review Article
94 TDP-43 frontotemporal lobar degeneration and autoimmune disease Journal of Neurology, Neurosurgery & Psychiatry, April 23, 2013 Review Article
95 A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies Rheumatology, April 23, 2013 Review Article
96 Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis Arthritis Research & Therapy, April 22, 2013 Clinical Article
97 Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment American Journal of Hematology, April 22, 2013 Clinical Article
98 ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review Clinical Rheumatology, April 22, 2013 Review Article
99 Variable presentation of primary immune deficiency: Two cases with CD3 gamma deficiency presenting with only autoimmunity Pediatric Allergy and Immunology, April 22, 2013
100 Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis Annals of Rheumatic Diseases, April 22, 2013 Review Article
Clinical Pearls in Rheumatology
- Independent predictors of disease activity in patients with systemic lupus include age, renal activity, immunosuppressant use and pre-existing organ damage
- When treating rheumatoid arthritis (RA), male sex, short duration of symptoms and less tender joints at baseline were found to be independent predictors of sustained remission with conventional DMARDs
- Higher baseline DAS28 scores and positive rheumatoid factor status are significantly associated with an improvement in response to rituximab treatment
Highlights in Rheumatology
ACPA correlate with disease progression in JIA
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryPredicting cardiovascular mortality in SLE
In a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryAnti-apoA-1 antibodies predict cardiovascular disease in RA patients
In a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summaryMost Popular Rheumatology Articles
Last month's top read Top Articles of 20121 Targeted therapies for systemic sclerosis Nature Reviews Rheumatology , April 10, 2013
2 Current diagnostic tools for Sjogrens syndrome International Journal of Clinical Rheumatology, April 3, 2013
3 Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis Arthritis Research & Therapy, April 22, 2013
4 Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India Rheumatology International, April 8, 2013
5 Skin and Mucosa Care in Systemic Sclerosis - Patients' and Family Caregivers' Experiences and Expectations of a Specific Education Programme: A Qualitative Study Musculoskeletal Care, March 28, 2013
6 The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis Annals of Rheumatic Diseases, March 25, 2013
7 A meta-analysis of healing and prevention of digital ulcers (DU) in systemic sclerosis (SSc) Arthritis Care & Research , April 2, 2013 Evidence Based Medicine
8 Risk factors for body composition abnormalities in systemic sclerosis Clinical Rheumatology, April 4, 2013
9 Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis The Journal of Rheumatology, April 18, 2013
10 Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies Annals of Rheumatic Diseases, April 9, 2013
11 Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study Rheumatology International, April 26, 2013
12 Interleukin-6: a new therapeutic target in systemic sclerosis Clinical & Translational Immunology, April 19, 2013 Free full text Review Article
13 Relationship between interleukin-6 and cardiac involvement in systemic sclerosis Rheumatology, April 1, 2013
14 Thrombosis in vasculitis Best Practice & Research Clinical Rheumatology, March 21, 2013 Review Article
15 ESSDAI and ESSPRI: EULAR indexes for a complete picture of primary Sjogrens syndrome patients Arthritis Care & Research , March 6, 2013 Review Article
16 Autoantibodies in Polymyositis and Dermatomyositis Current Rheumatology Reports, April 24, 2013 Review Article
17 Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile Annals of Rheumatic Diseases, April 15, 2013
18 Why is epigenetics important in understanding the pathogenesis of inflammatory musculoskeletal diseases Arthritis Research & Therapy, April 5, 2013 Review Article
19 Anti-citrullinated protein antibodies (ACPA) in unaffected first degree relatives of rheumatoid arthritis patients Arthritis & Rheumatism, March 4, 2013
20 Update on Stem Cell Transplantation for Systemic Sclerosis: Recent Trial Results Current Rheumatology Reports, March 22, 2013 Review Article
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Other Topics in Rheumatology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close